Drug Trial Radar · NCT03754790
Long-term Safety and Efficacy Study of Fitusiran in Patients With Hemophilia A or B, With or Without Inhibitory Antibodies to Factor VIII or IX
Last checked: Nov 19, 2026Latest source record: Sep 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
281
Actual
Start
Jan 9, 2019
Primary completion
Sep 14, 2026
Study completion Sep 14, 2026
Sponsor
- Lead sponsor
- Genzyme, a Sanofi CompanySanofi (SNY)
- Sponsor type
- Industry
- First posted
- Nov 27, 2018
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- Male only, from 12 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Primary Objective: To characterize the long-term safety and tolerability of fitusiran Secondary Objectives: * To characterize the efficacy and long-term efficacy of fitusiran as assessed by the frequency of: * Bleeding episodes * Spontaneous bleeding episodes * Joint bleeding episodes * To characterize the effects of fitusiran on health-related quality of life (HRQOL) measures in participants ≥17 years of age
Conditions
- Hemophilia
Interventions
FitusiranDrug
Pharmaceutical form:solution for injection Route of administration: subcutaneous
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of participants with treatment emergent adverse events (TEAEs)Time frame: from study baseline (day 1) up to maximum 88 months
Locations
79 sites in 20 countries. Site status is shown where the registry gives one.
Phoenix Childrens Hospital Site Number : 8400009
Phoenix, Arizona
Children's Hospital Los Angeles Site Number : 8400019
Los Angeles, California
Center for Inherited Blood Disorders (CIBD) Site Number : 8400016
Orange, California
Nemours Children's Clinic Site Number : 8400008
Jacksonville, Florida
St Joseph's Children's Hospital of Tampa Site Number : 8400002
Tampa, Florida
Rush University Medical Center -1725 W Harrison St Site Number : 8400001
Chicago, Illinois
~Massachusetts General Hospital Site Number : 8400011
Boston, Massachusetts
University of Michigan Hospital - 1500 E Medical Center Dr Site Number : 8400012
Ann Arbor, Michigan
Alliance for Childhood Diseases Site Number : 8400007
Las Vegas, Nevada
Childrens Hospital Medical Center of Akron Site Number : 8400006
Akron, Ohio
Investigational Site Number : 0360001
Camperdown, New South Wales, Australia
Investigational Site Number : 0360003
Prahran, Victoria, Australia
Investigational Site Number : 0360002
Murdoch, Western Australia, Australia
Investigational Site Number : 1240001
Montreal, Quebec, Canada
Investigational Site Number : 1560004
Beijing, China
Investigational Site Number : 1560007
Beijing, China
Investigational Site Number : 1560014
Changsha, China
Investigational Site Number : 1560009
Chengdu, China
Investigational Site Number : 1560002
Guangzhou, China
Investigational Site Number : 1560011
Guiyang, China
Investigational Site Number : 1560005
Hangzhou, China
Investigational Site Number : 1560008
Jinan, China
Investigational Site Number : 1560012
Kunming, China
Investigational Site Number : 1560013
Lanzhou, China
Investigational Site Number : 1560010
Qingdao, China
Investigational Site Number : 1560003
Shanghai, China
Investigational Site Number : 1560006
Suzhou, China
Investigational Site Number : 2080001
Copenhagen, Denmark
Investigational Site Number : 2500002
Lyon, France
Investigational Site Number : 2500003
Paris, France
Investigational Site Number : 2760001
Berlin, Germany
Investigational Site Number : 2760003
Leipzig, Germany
Investigational Site Number : 3480002
Budapest, Hungary
Investigational Site Number : 3560001
Bangalore, India
Investigational Site Number : 3560005
Lucknow, India
Investigational Site Number : 3560007
Mumbai, India
Investigational Site Number : 3560002
Pune, India
Investigational Site Number : 3560010
Pune, India
Investigational Site Number : 3560004
Ranipet, India
Investigational Site Number : 3720002
Dublin, Ireland
Showing 40 of 79 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.